ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000872.1|A-90289_1 # 1 # 546 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.734	BGC0000872.1|A-90289_1 	1	546	-	Loose	700	24.2534	DHA-15	35.42	3002146	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	ATGACCACCACCCCGCCCCTCGTAGACCCCCGCGTCATCGCCCTGGCCCACTACGCCGGCCGGGCTCTATTGGAGAACGTGCTGGCCCGGCACGGCATCACCTTCCAGCAGTCCGTCGCCCTCCGGCTCGCCGCCCTCGCCGACGGCCCTGTCGCACGGGAACGGCTCGTCGAGGGCGTCACCGGCGCCCTGAAGATCGGCGCTTCGGAGGTGCACGGCGTGCTCGACCAACTGATCACCGCGCGGCTGCTGACCCCGGACGGGGCGCCGGAATCGGCCTCGACGACCTCCAGCCACTTGCGGATCACGGACGCCGGGCGGGAGCTGTACACCACGACCTCGGGCGCGACGGCTCCCGTCACCGCCCGGATCTACGACGGCATCCCGGCGCAGGACCTGGCCGTCACGGGCCGGGTGCTGAGCCTGATCACCGAGCGGGCCGATGCGGAGCTGGCCGCCCTGACGCGCTGGCCCCGGCCCCTGTCCGGCCGGCGGAATATCCGGCCCACGGGCTCGGTTGTCGGCCGCGAAGGAGGCACCGAGTGA	MTTTPPLVDPRVIALAHYAGRALLENVLARHGITFQQSVALRLAALADGPVARERLVEGVTGALKIGASEVHGVLDQLITARLLTPDGAPESASTTSSHLRITDAGRELYTTTSGATAPVTARIYDGIPAQDLAVTGRVLSLITERADAELAALTRWPRPLSGRRNIRPTGSVVGREGGTE	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGYMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	47.76	gnl|BL_ORD_ID|26|hsp_num:0	32			522	660	
BGC0000872.1|A-90289_2 # 543 # 740 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0000872.1|A-90289_2 	543	740	-	Loose	280	25.0238	emrR	29.41	3000516	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCAGCTCGCCCTGACCGAGCAGGGCCTCGACGTCACCCGGCGGGCGATCGAGGTCGTCCAGGGACTCCTCCAGCAGCTCCTCGACCCGCTCGGCGGCCTCGGCAGTGCGCGCACCAGGGAGTTCACACGCGAGCTGACGGCCCTGCTCGACGCGCCCCTTGATCCCTTCAGCGAGAACGAGACGGAGCAGCCATGA	MQLALTEQGLDVTRRAIEVVQGLLQQLLDPLGGLGSARTREFTRELTALLDAPLDPFSENETEQP	MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS	36.93	gnl|BL_ORD_ID|1225|hsp_num:0	1330			336	489	nalidixic acid
BGC0000872.1|A-90289_4 # 1894 # 3423 # -1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=AGGGA;rbs_spacer=10bp;gc_cont=0.681	BGC0000872.1|A-90289_4 	1894	3423	-	Loose	280	26.5646	FosA6	28.79	3004111	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	TTGGTCCGGACGAGAACGACAGCCGCGTCACGGCGCTCCAGGAGCACACGGCGCGCGTTGACACTGCTCGTGGGGGCCGTACTGGCCCTGGCGCTGGGCAACGCTCCGGGGGCATCGGCGAATTCGCCCTCGTTCCCCGGTCACCCCAGGTCCTTCGTGACCCGGCCCGATCTTCTCCCCCCGGCCGTCACCGTGGGCGAGTCCGCGCCGGGAACGGCACCGGGCTACGTCTTCCTCGCACCGAAGACGGGCGATGTGACGCAGGGGCCGGGCACACTCCAGTCCGGGCCGATGATCGTGGACGACGAGGGTGAGCCCGTGTGGTTCCTGCCGCGGGGCATCGGTGCCCTGAACTACGTCACGGCGTTCCAGCAGCAGACCTACCGGGGCGACCCCGTCCTCACCTGGTGGGAGGGCGCACCACTGCCCACGGGGGTCGGAGTCGGCTACTGGGTCGTGATGGACCAGTCGTACCGCGAGATAGCCCGCATCAGGGCGGGCAGCGGGTATGCGGGGGCCGATCTGCACGACATGCAGATCACCCCTGACAACACGGCACTCGTGCTCATCGCTCAGCCGAAACTGCACAGGGGCGGCGGTTTTCCCCGCATGGTGATGGACAACATCGTCCAGGAGGTCGACCTGCCGTCCGGAAAGGTGATCCACGAGTGGAGCGGCCTCGATCACGTGGGCGTCGACGAGTCCTACCTGTCCTCCATCCCGCTGCTGCCCTACGACTACCTGCACATCAACTCGATGTCCCTCGACACCGACGGAAACCTGCTCCTCAGCGGACGCAACACCCATACGGTGTACAAGATCGACCGCAGGAGCGGCGAGGTCATCTGGCGTCTCGGCGGCAAGAAGAGCGACTTCACCATGGCGGACGGCGCCTCCTTCGCCTGGCAGCACGATGTGAGCAGGGAGGAGGACGGCACCCTGTCCGTTTTCGACAACGCCGCCGCCGGCAGCATCGAGACGGGCGGTGGCGAGCAGTCGGGAACCACGTCCCGCGCCGTGTTCCTGTCGCTCGACACCGCTACGAGGACCGCCAAACCGGACAGGGCCTACACGAGTCCGGACGGACTGCTGTCCACGAGCCAGGGCAGCGTGCAACTGCTGCCGAACGGCAATGTTCTGGTGGGATGGGGTTCCCACGGCTACTACACCGAGTACGCGGCCTCCGGCAAAGTCCTCATGAACGCCTTCTTCAAGGATCCGGTGGTGAACTCCTATCGCGCCCTCCGCTTCCCGTGGCAGGGCAGGCCGGCCGACCGGCCCGCCGTCGCAGGCCGGTCCAGCGGCAACGGCATGACGCTCCACGCCAGTTGGAACGGAGCGACCGCCGTGGAGTCCTGGAGGTTCCTGGCGGGCGACACCCCGCAGGGACTGATCGCGGTGGAGGAGGTCCGCAGGGACGGATTCGAGACGTCGGCCACGGCGGCCCGCAGGTCGTCGTACGTGGCCGTGCAGGCTCTCGACGGCACGGGGCGGGTGATCGGCACCTCGGCGACCGCGCGGGTGCGCTGA	MVRTRTTAASRRSRSTRRALTLLVGAVLALALGNAPGASANSPSFPGHPRSFVTRPDLLPPAVTVGESAPGTAPGYVFLAPKTGDVTQGPGTLQSGPMIVDDEGEPVWFLPRGIGALNYVTAFQQQTYRGDPVLTWWEGAPLPTGVGVGYWVVMDQSYREIARIRAGSGYAGADLHDMQITPDNTALVLIAQPKLHRGGGFPRMVMDNIVQEVDLPSGKVIHEWSGLDHVGVDESYLSSIPLLPYDYLHINSMSLDTDGNLLLSGRNTHTVYKIDRRSGEVIWRLGGKKSDFTMADGASFAWQHDVSREEDGTLSVFDNAAAGSIETGGGEQSGTTSRAVFLSLDTATRTAKPDRAYTSPDGLLSTSQGSVQLLPNGNVLVGWGSHGYYTEYAASGKVLMNAFFKDPVVNSYRALRFPWQGRPADRPAVAGRSSGNGMTLHASWNGATAVESWRFLAGDTPQGLIAVEEVRRDGFETSATAARRSSYVAVQALDGTGRVIGTSATARVR	MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEAAGVAIWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQQYKGMVFFDQ	366.19	gnl|BL_ORD_ID|2397|hsp_num:0	2779			48	246	fosfomycin
BGC0000872.1|A-90289_5 # 3452 # 4714 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGAGG;rbs_spacer=13bp;gc_cont=0.701	BGC0000872.1|A-90289_5 	3452	4714	-	Loose	300	28.4906	poxtA	31.91	3004470	protein homolog model	n/a	n/a	tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGGTCAGCGATTTCGCCATCGGAATTCACGATCTTTCGTTTTCCACAACGGAATTCGTCCTGCCGCACGCGATACTCGCCGATCACAACGGCACCGAAATCAACAAGTACCACGTGGGTCTCGGCCAGCGGTCGATGAGCGTGCCCGCCGCCGACGAGGACATCGTCACCATGGGAGCGACCGCCGCCGAGCCGATCATCGCCCGGCACGGCACCGACCATGTCCGCACGGTCGTGTTCGCGACGGAGTCGTCGATCGACCAGGCGAAGTCGGCCGGCGTGTACGTGCATTCGCTGCTGGGACTTCCGTCGGCCACCAGGGTCGTCGAACTGAAGCAGGCTTGCTACGGGGCGACGGCGGCCCTGCAGTTCGCCCTCGGACTCGTGCGCCGCGATCCCGTCCAGCGGGTACTCGTGATCGCGAGTGACATCTCCAGGTACGACCTGGACAGCCCGGGTGAGGCGACCCAGGGCGCGGCGGCGGTGGCCATGCTGGTGGGCTCCGACCCCGCCCTGCTGCGCCTGGAGGAGCCGTCGGGCCTGTTCACCGCCGACGTCATGGACTTCTGGCGCCCGAACTACCGCGACGCCGCGCTGGTCGACGGCCAGGAGTCCGTCAGCGCCTACCTGCGGGCGGTACGGGGCACGTGGGGGGACTACACGGACCAGGGGGGCCGTCCCCTCGACGAGTTCGCCGCGTTCTGCTACCACCAGCCGTACGCGAAGATGGCCTACAAGGCGCATCGCCACCTGCTGGAGCACTGCGGGCACCCCACCGGCGAGGCGGAGGTGGCGCGAGCCGTCGGGCGGACCACCGCCTACAGCGCCGTCATCGGCAACAGCTACACGGCGTCGGTGTACCTCGGCTTGGCCGCGCTGCTCGACGAGGCGGACGACATGACCGGCCGGCCGATCGGCTTCATGAGCTACGGCTCCGGAAGCGTCGCCGAGTTCTTCGGCGGCACCCTCGCCCCCGGTTACCGGGAACACCTGCGGACCACGGCCCATCGCGGGGTCCTCGACCGGCGGCAGCCGGTCGACTACGCGACCTACCGCGAGCTGTATGAGCGTTCCTTCCCGGCGGACGGCGGGGACCACCCGACGCCACCCCAGACGACCGGGCCCTTTCGGTTGGCAGGGCTGCGCGGCCATCAGCGTGTCTACGAGCGGCGGGCGCCCGTGTCCGCGCGCAGCTCGGCGGAGGCCGGTGACCTCCGGCGCCTGCCGCACGAGGGCCACCGCCCGGCACCCGCCACATCCTGA	MVSDFAIGIHDLSFSTTEFVLPHAILADHNGTEINKYHVGLGQRSMSVPAADEDIVTMGATAAEPIIARHGTDHVRTVVFATESSIDQAKSAGVYVHSLLGLPSATRVVELKQACYGATAALQFALGLVRRDPVQRVLVIASDISRYDLDSPGEATQGAAAVAMLVGSDPALLRLEEPSGLFTADVMDFWRPNYRDAALVDGQESVSAYLRAVRGTWGDYTDQGGRPLDEFAAFCYHQPYAKMAYKAHRHLLEHCGHPTGEAEVARAVGRTTAYSAVIGNSYTASVYLGLAALLDEADDMTGRPIGFMSYGSGSVAEFFGGTLAPGYREHLRTTAHRGVLDRRQPVDYATYRELYERSFPADGGDHPTPPQTTGPFRLAGLRGHQRVYERRAPVSARSSAEAGDLRRLPHEGHRPAPATS	MKGKNMNLAFGLEEIYEDAEFQIGDLDKVGIVGVNGAGKTTLFRLLLGELELDNGSLTSGNARIGYLPQEIVLEDEDITVWDFLFEGRPIKKYEQELEEIYKKLETAVNAEQEALLARMGTLQERLEYFDFYEAETILLEFADKMSIDAELYHRPMRELSGGQKSKMAFARLLYSKPEILLLDEPTNHLDVSTKDFVIKYLKNYRGSVLIISHDIDFLNRIINKIMYINKATHKISVYDGDYYIYKKKYAEEQRIREMAIVQQEKEIKELSDFVQKAKQASQTNHHLKRMGQERALRLDKKRGELQKRNRLYKRVKMDIRPKREGAQVPLEVENITFHYSGYPTLYQNLSFQINGRERFLVVGENGVGKSTLLKLMMGILSPDEGCIRFNQKTDIAYYAQELEQLDENKTVIDNVESEGYTPWQIRAVLSNFLFYDDDVNKKVSVLSPGEKARVALCKILLQKANLLILDEPTNHLDPETQKIIGGNFNLFEGTIIAVSHNPSFVEQIGISRMLILPSGRIEPYSRELLEYYYEINGSVAKF	77.49	gnl|BL_ORD_ID|2510|hsp_num:0	2904			489	630	tetracycline; doxycycline; linezolid; chloramphenicol; florfenicol
BGC0000872.1|A-90289_6 # 5208 # 6062 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.712	BGC0000872.1|A-90289_6 	5208	6062	+	Loose	500	30.4166	rmtD2	32.69	3004677	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGGCGCGGCGCAACCGGACCGCGTTCGCCGACGCCTGCGGCATGGCGGTGGACGCAGCGCGCCGTGCGCTTGCGGGGACCGGACTCGCCGCCGATGACATCGACGCGATCGTCACCAGCCACACCACGTCCTGGACGCTGCCGAATCTCGACACCCACCTCGTCGCAGCGCTCGGTCTCCGCCCGGACGTGTCGCGCATCGCCCTCACGTCACTGGCGTGTGCCGGCGGAGCCCAGGCCCTCGTCCGGGCTACGGACCTGCTCAGGGGACGGCCGGGCGGCAAGGTGCTGGTGGTGGTGGCGGAGGTGCTGTCCACCACCTTTCACGCGCATGAGGACAACATCGAAAGCATGATCTACAAGGTGCTGTTCGGTGACTCCGCGGGCGCCTGCGTCGTCAGCGATCTGCCGCTGGAACCGGGTTTCGCCATCGAATCCACCTTCGAGTACGTCCTGCCGGACTCACTGGACCGCTACTGGGGTGAGGTGGACGCCGCCGGAGCCCACTTCAGGTCGACGAGGAAGGCGCTCGGCGCGCCCGGGGAGGCCCTCCCGGGGGTCCTCGGGTGGCTCGGCTCGTGGCGGCCGGAGTTCGCCGTGGTCCACCCCGGCGGCCCCCGGATCATCTCGGAGGTCACCGCGGCGCTGGGGCTCGGCGCCGAGGAGACCCGGCATTCGTTCGCCTCGCTGGAGGAGAACGGCAACCTCGGCGGCAACGCGGTCCTGGACGTGCTCGGCCGGAGCCACGCGACCCCGCCGCCCGACGGGGCCGAAGGTCTCATCATCGCTTTCGGGCCCGGATTCACCGCCACCTGCGCGCGTGGCGTGTGGCGCGCCCCGACTACAGAAGGGTAG	MARRNRTAFADACGMAVDAARRALAGTGLAADDIDAIVTSHTTSWTLPNLDTHLVAALGLRPDVSRIALTSLACAGGAQALVRATDLLRGRPGGKVLVVVAEVLSTTFHAHEDNIESMIYKVLFGDSAGACVVSDLPLEPGFAIESTFEYVLPDSLDRYWGEVDAAGAHFRSTRKALGAPGEALPGVLGWLGSWRPEFAVVHPGGPRIISEVTAALGLGAEETRHSFASLEENGNLGGNAVLDVLGRSHATPPPDGAEGLIIAFGPGFTATCARGVWRAPTTEG	MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDADKAAREALHGVTGAFMTEREYKRAMELAATRDWEALLGMHASTRERLPVESMDRVFDQLFEAIGTPARILDLACGLNPVYLAHRLPNAAIAGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEADAALMFKVLPLLERQRTGAAMEALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENELFYVLKRK	114.98	gnl|BL_ORD_ID|2225|hsp_num:0	3376			9	156	amikacin; netilmicin; kanamycin A; tobramycin; gentamicin A; gentamicin
BGC0000872.1|A-90289_7 # 6619 # 7257 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.685	BGC0000872.1|A-90289_7 	6619	7257	+	Loose	550	26.9498	LRA-2	25.29	3002485	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	ATGAAGATCATCGGAGCCGGTTTCGGCCGGACGGGGACGCTGTCGGTGAAGGCCGCCCTGGAGACACTCGGTCTCGGACCCTGCTACCACATGCTGACCGCCTTCGAAGAGCCCGGGCACCTCCGCCTGTGGAACGCTGCCGGCCGGGGCGAGCGGGTCGACTGGACGGAGATCTTCGCCCGGTACGAGTCCACTGTGGACTGGCCGGGGTGCGATCACTGGGAGACGCTGGCCAAGGAGTACCCGGACGCGAAGATACTGCTGACCGTGCGGGACCCGGAAGGGTGGTACGACAGCTTCCTGCAGACGCTCGCACCGCTGTGGTCGGCCGAGTCCGACGACCCGGAAGTCCGGGAGTACCTGGAGCTGGTGCGGCGCATTTCCGCCCGCACCTTCGACGGACGCCTCGACGACCGGGCCCATGCCATCGCCGTGTTCGAGGATCACATCCGGAGGGTCCGTGCCGCGGTCCCGGCCGACCGGCTGCTCGTCTACGACGTCCGCCAGGGCTGGGAGCCGTTGTGCGCGTTCTTCGGCAGGCCGGTGCCGCCGGACACCGACTTTCCCCACCTCAATGACCGTGCGCGATTCCAGGAACTGCTCAGCCGACGCTTCGCTCAGCGCGGCGACCCGCGATGA	MKIIGAGFGRTGTLSVKAALETLGLGPCYHMLTAFEEPGHLRLWNAAGRGERVDWTEIFARYESTVDWPGCDHWETLAKEYPDAKILLTVRDPEGWYDSFLQTLAPLWSAESDDPEVREYLELVRRISARTFDGRLDDRAHAIAVFEDHIRRVRAAVPADRLLVYDVRQGWEPLCAFFGRPVPPDTDFPHLNDRARFQELLSRRFAQRGDPR	MMDGIKKKTAAGAAAGSLLMMLGVFATPAAGGEAAFKDCPQCAQWNQQRKPFRIYGNTYFVGTAGLSSILVTSDYGHVLIDGGLAQSAPLIKANIEALGFKLTDVKAILVSHVHPDHAGGVAELQRQSGAQVYALRTAEAVLRTGRLTQDDPQSASKTATITPVPQVWVVQDDQLLGVGALRMRAIATPGHTPGGTSWTWDACEDGNCLKMIYADSLSAVAAGKYRFKDHPEVLQAFASSFSRAESAPCDVLLTPHPDASQLFQRLDPEGGTRAASIKDDTACRRYVQAARDTLARKLASEG	70.20	gnl|BL_ORD_ID|1218|hsp_num:0	1324			660	894	
BGC0000872.1|A-90289_8 # 7697 # 8464 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.694	BGC0000872.1|A-90289_8 	7697	8464	+	Loose	230	48.1358	ramA	33.62	3000823	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	ATGCTGGACGCGGATCCCGGACAGCACGCGCTCGTCCTGAGCGCGTGCGGCGAGATCAGGGTGACTCGCGCCGAGCGCGAAGTCCTCGTCCAGGACGAGGCGGTGGCACTGTGTGACAGGCGGCAGCCGGTGCACATCAGCCCGACGCCCGGCCATCCGACCGCCGAGGCGGCCGTGATGCTCTTCCCGGGCTCGGCTGTGCCGATGGCCCAGCCGGAGTCCGATCCGTCGCAACCCGAGATCTGCGATGCCGCGGGATCCGGGCCGCTGCTCCGCGCGTTCCTCGTCGAAGCGGTCACCCGGGCGTCCGAACTCAGCCCGACGGAGGGGGCCCGGCTGGGCGATGCCGCCCTGCACCTGGCGGCGGCGGTGCTGGAGGCGCACTTCGCCGATGCCGGCGAAACGAGCGCGCAATCCCAGCAGCAGGAGCTCATGACGCGCATCCGGGGTTTCATCGACCGCAACCTGCGCGATCCCTACCTCACTCCTAGCATGGTCGCCTCGGCGCACCACATCTCCATCCGCTACCTGCAACGGCTGTTCAAGGCGGAGGGCATCACACCGTCGGACTGGATACGGCAGCGCAGGCTCGACAACAGCCGGCGTGACCTCTGCGACGAGAAGCTGAGGTCGGCATCGATCCGGGAGATCGGCCTGCGGAACGGTTTCGCGCAACCCTCCGATTTCAGCCGTGTGTTCCGCGCCCACTACGGCGTGCCGCCGGGGCGATTTCGCGACGACTGGTTGCGCCGGGGCGCGATCGGATAA	MLDADPGQHALVLSACGEIRVTRAEREVLVQDEAVALCDRRQPVHISPTPGHPTAEAAVMLFPGSAVPMAQPESDPSQPEICDAAGSGPLLRAFLVEAVTRASELSPTEGARLGDAALHLAAAVLEAHFADAGETSAQSQQQELMTRIRGFIDRNLRDPYLTPSMVASAHHISIRYLQRLFKAEGITPSDWIRQRRLDNSRRDLCDEKLRSASIREIGLRNGFAQPSDFSRVFRAHYGVPPGRFRDDWLRRGAIG	MINQEAEGESSMTISAQIIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLLAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSRAH	205.65	gnl|BL_ORD_ID|1537|hsp_num:0	1665			21	354	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000872.1|A-90289_9 # 8644 # 9165 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.634	BGC0000872.1|A-90289_9 	8644	9165	+	Loose	275	29.6462	AAC(6')-IIa	34.78	3002594	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGACAGCACTCACGTCCAGGACCGAGCTCGACATCGACCCCGGAAAGCTCCAGGAATCCGTGACCAACCTGCTGGAAAGGCATCCACTCGTCTTCGACGGAACACGTCAGTTGGCGCTCCAGCACCGGCCGGGGGCGACGGACCCGTGGTACGAGGGCTGCCAGCGGCAGTCCTTGATCTCCTCGGACTCCCACTTCACCGAAGTGCACGCCGAACTCAGGGACACCTACCTGGGCGAGGTGTTCGAGCGGCTTCCGTTCAAACCCATTCGCACGAGGATCATGGCACTGGACTCGAAGTACTGCTATTCGGTCCACCGGGACCTGACGCCGCGATACCACCTCGCCGTCGCCACGAGTGAGCATGCGCGGTTCGTGTTCATCGAGCACGAAAAGGTGCTGCACATCCCCGCGGACGGAAGCCTGTACTACGTCGACACGCGGGAACTGCACAGCGCGTTCAACGGCGGGGACGACATGCGCGTGCACATCGTGTTCGGGACGGACGGCGAGCCGGAGTAG	MTALTSRTELDIDPGKLQESVTNLLERHPLVFDGTRQLALQHRPGATDPWYEGCQRQSLISSDSHFTEVHAELRDTYLGEVFERLPFKPIRTRIMALDSKYCYSVHRDLTPRYHLAVATSEHARFVFIEHEKVLHIPADGSLYYVDTRELHSAFNGGDDMRVHIVFGTDGEPE	MSASTPPITLRLMTERDLPMLHDWLNRPHIVEWWGGDEERPTLDEVLEHYLPRAMAEESVTPYIAMLGEEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQSLADPTQLNKGLGTRLVRALVELLFSDPTVTKIQTDPTPNNHRAIRCYEKAGFVREKIITTPDGPAVYMVQTRQAFERKRGVA	94.02	gnl|BL_ORD_ID|1529|hsp_num:0	1657			396	525	dibekacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin; gentamicin
BGC0000872.1|A-90289_10 # 9186 # 9818 # 1 # ID=1_10;partial=00;start_type=TTG;rbs_motif=AGGGG;rbs_spacer=8bp;gc_cont=0.681	BGC0000872.1|A-90289_10 	9186	9818	+	Loose	550	26.1794	RlmA(II)	58.82	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	TTGACGAACTTGGTGGCGCACTGGGACCGCCGCGCCGAGAGTTATGACGAGACACCGGGCAACTCGCTGACGGCCGAGCAGGCGGCAGCGTGGAAGTCGCTGCTGGCGGAGATCTACCCCGTCCACAGGGGACGCCTTCTCGACATCGGCTGCGGCACGGGCACCTACTCGTTGCTGATGGGGGAACTGGGATTCGACGTCCATGGTGTCGACACGTCACAGCGGATGATCGAGCGGGCGCGAGCGAAGGCACTCGGGTGCGGAGCCGGAGCTGCCGTCACCTTTTCGACGCTCGCCGCGCAGGACATCAGCGGCCGGTACGACGCGGTGTTCTCACGGAACGTGCTGTGGACCGTGGCCGACCCCGGCCGGCTCGCCGAGGTGGTGCGCGAGCACACCACGCAGGCCGCGGTGTGGGCCGCCGTCGAGACGGTGTGGGACGGCCGCCCGAAGGGCGACTTCAAGGCAGCGGGCAAGGATCTGCCCGGATTCGGCGGCTGGCATCCCAACGTGCTGCGTGACGAGTTCGCGCGTCACGGCTTCGCGGCGACGACGTGGTCGAGCATCTCCAACCGGGCTGATCTGGCGACCGAGGACAAGGACATCCACGTGCTGTTCAGGGTGAGCCGGTGA	MTNLVAHWDRRAESYDETPGNSLTAEQAAAWKSLLAEIYPVHRGRLLDIGCGTGTYSLLMGELGFDVHGVDTSQRMIERARAKALGCGAGAAVTFSTLAAQDISGRYDAVFSRNVLWTVADPGRLAEVVREHTTQAAVWAAVETVWDGRPKGDFKAAGKDLPGFGGWHPNVLRDEFARHGFAATTWSSISNRADLATEDKDIHVLFRVSR	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	74.47	gnl|BL_ORD_ID|2052|hsp_num:0	2274			294	345	tylosin; mycinamicin
BGC0000872.1|A-90289_11 # 9815 # 10384 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=AGGG;rbs_spacer=7bp;gc_cont=0.675	BGC0000872.1|A-90289_11 	9815	10384	+	Loose	375	43.5134	tmrB	29.06	3003059	protein homolog model	n/a	n/a	nucleoside antibiotic	reduced permeability to antibiotic	tunicamycin resistance protein	GTGATCATCGTCATCACGGGCCCCTGGGCACTGCCGAGGATGGACATCGCGCGCACGGTCGCCGGCCGGCTCAGCGGCGCGGAGGCCGTCGATGGGGAGCAGTTGGGATTCGCCCTGATGGAGTTCCGCTCCGACCTGCCGGACAACTTCCAGGAGGACACCGTCTGGGAGGCGCTGTTCACGGCGTTGTGCGTGCACACCGCCCGACGCCGGAACGGCACCTGCGTGCTGGCACCGATGAACATCCATTCCAGTGAGCGTCTGACCAGGGTGCGGACGGACATCACCCTGCAGGGAGAAACCGTCCACGTCGTGGGTCTGCGGTCCTCGCGGGAGCAGTGTGAGCGCCTGGCGGACACCTTCTCGTTCTTCGAGAAGGGCTCGGCGGACTACCATCGCGTGCGCGACTGGCAGTTGGAGCGTCTGGACGAGTACCTGAAGTTCGTCGCAGACCCCCAGGCGCCGGTGGACCGCTGGATCGACCTGGTGCCGGACGCGTCCGCCCGATGGGTGGCTGCTTCGATCACCAGGGCCATCACCCCCCTGGTCGCGGCAGGGACGGCCACATGA	MIIVITGPWALPRMDIARTVAGRLSGAEAVDGEQLGFALMEFRSDLPDNFQEDTVWEALFTALCVHTARRRNGTCVLAPMNIHSSERLTRVRTDITLQGETVHVVGLRSSREQCERLADTFSFFEKGSADYHRVRDWQLERLDEYLKFVADPQAPVDRWIDLVPDASARWVAASITRAITPLVAAGTAT	MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLWRAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSLRRFADRLMVKLNHIRIK	95.94	gnl|BL_ORD_ID|1654|hsp_num:0	1794			0	339	tunicamycin
BGC0000872.1|A-90289_12 # 10449 # 11771 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=11bp;gc_cont=0.695	BGC0000872.1|A-90289_12 	10449	11771	+	Loose	500	28.8758	OXA-60	48.28	3001808	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACGACGTGTGCGGAGGACGTCGTGGCGGAGGTCCGCGACGCCGAGTGCGTGGTCGCGTACCGGCGTCTGCGGAACGGGGTCCGCACCACGCGCCAGATCGGTTACGGCCGCAACATGTATCCGGCCGCGCCGGAACTGGTGGCGCAGATCCGCGGGCTGATCACGGTGCTGTTCGCCCAGCAGCGCATGACGGACTACTCGACCGAGTTCGACGGCAGCGACCGGCAGCTGATCAGCGCGCTGGCCGGAAGGTGGCTGAGGCGCCCGGACATCGAGCGGGACGACGTGTTCGTGATGTCCGGGTCCACCGAGGCGATCAGCGTGGTCACCGGCTACCTCTCCGGACGCGGGTACGGGTACGTCCTGCCGCTGCCCTGCTACTACGCCTTCGAGCAGTCCGCCCGACGCTGGGGGATGCCGGTTCACGGGCACTACAACGGTGACGGCAGCGTGCATGTCACCCGGAGGGGCTCGCCGAGCGCCCTGGTCGACATCGTGCCGAACGGCGTGACCGGCCAGCGGTTCCGGCTGCCCGACGGTGCCGACGACTTCCGGATCATCGACTCGGTGTTCCAGGTGTCCCCGGCGCCCGGCCCGGGGACCGCCGTGGACGATCAGCACCTGCTCGACGCCGTACGGGAGGTCGATCTCGGTAAAGGCTGCGTCATGCTGACCGCGAGCAAGGACCTGTCGGTCCCCGGACTGCGCGCCGGCCTGCTGATCACCAAGGAGCCCGGCCTCAGGCAATACCTGGAGGCGGACCGGTTCGAGCGGTGCTATTCGCTGAACCCGCTGTCCACCAGCATGATCGCCCTGTACGTCGCACTGATGTGCGCGCGATCGTCGCGGGCGGAGGGTGGCGCGGCATCCGAGCGCCCGCTGGTCCCGCCCGAGGTCGCGCTGAGCCGGCCCGCCCCCGGCGACCCGCTGCAGAGGCTGCTGTGGCAGTCGCCGATCGTCGACGCCCTCGACCGCTATCTGATCGGCATGGCCCGGCACTACGAGGCCGTCCTGCGGATTTACCAGGACCGTCTGGCCCCGCTGGGGATCGATGTCGCCGTCCGGCGTCCGGAGACCGGCTACTCCCTGTTCCTGCCGCTGCCGGTAAGGGTCGACGGGCCGGAGGGGGCTGTGCAGTGGTGCAACCGGGTCGGCAGGGAGAGGGGACTCAAGCTCAATCCAGCAGCGATCTTCGGGGGAAGCGACGAGCCGTGGACGGCCCTGTACGACTGCACGCGCCCATGGGTGCGCTTCAACTGTTCGGTCGCGGAGCCGGATGCCCTCGGCACCGTGGACATCCTTGCAACGGCATTGAGGTGA	MTTCAEDVVAEVRDAECVVAYRRLRNGVRTTRQIGYGRNMYPAAPELVAQIRGLITVLFAQQRMTDYSTEFDGSDRQLISALAGRWLRRPDIERDDVFVMSGSTEAISVVTGYLSGRGYGYVLPLPCYYAFEQSARRWGMPVHGHYNGDGSVHVTRRGSPSALVDIVPNGVTGQRFRLPDGADDFRIIDSVFQVSPAPGPGTAVDDQHLLDAVREVDLGKGCVMLTASKDLSVPGLRAGLLITKEPGLRQYLEADRFERCYSLNPLSTSMIALYVALMCARSSRAEGGAASERPLVPPEVALSRPAPGDPLQRLLWQSPIVDALDRYLIGMARHYEAVLRIYQDRLAPLGIDVAVRRPETGYSLFLPLPVRVDGPEGAVQWCNRVGRERGLKLNPAAIFGGSDEPWTALYDCTRPWVRFNCSVAEPDALGTVDILATALR	MLSRYSKTLAFAVVACTLAISTATAHAELVVRNDLKRVFDDAGVSGTFVLMDITADRTYVVDPARAARSIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYEQWEHDMALPEAIRLSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGSAIDQFWLRGPLEISAFEEARFTSRMALKQLPVKPRTWDMVQRMLLIEQQGDAALYAKTGVATEYQPEIGWWAGWVERAGHVYAFALNIDMPREGDMAKRIPLGKQLMRALEVWPAP	162.36	gnl|BL_ORD_ID|38|hsp_num:0	47			408	495	cloxacillin; oxacillin; cefalotin
BGC0000872.1|A-90289_13 # 11776 # 13050 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.686	BGC0000872.1|A-90289_13 	11776	13050	+	Loose	500	27.335	APH(3')-IIa	45.95	3002644	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GTGACGGTGGGGGCTGGTGGAAAGACGTCTGCGGACGCTGACCCGCTGATGCTGGTCAGGGCGATAGCCGACGCCGACCGACGTGCGGCGCACGCACTCAACCTCGTGCCCAGTGAGAACCGGATCTCGCCCCTGGCGTCGTTGCCACTGGCATCCGATTTCTACAACCGGTACTTCTTCAACACCGACGGGGATCCGCTGTTCTGGGAGTTCCGGGGCGGAGAGGACATCGCCCACATCGAGGCGCTCGGAGCCGCGGCGCTGCGACGGATGGCCTCGGCGCGGTACTGCAACGTGCGCCCGATCTCGGGGATGAGCGCGATGATCCTCACCGTCGCCGCCCTGTCACCACCCGGATCGACCGTGGTGAGCGTCGACCAGAACTCCGGCGGTCACTACGCCACCCCGGCGCTGCTCGGCAGACTGGGCCGCCGCTCCCGGCTGCTCAACTGCAAGGACGGGGAGGTCGACGAGTCGGAACTCGCCGAGGTGCTCGCACCAGGCGACGTGGCGCTCGTATACGTGGACGTGCAGAACTGCGTCAGGGTGCCGGACTTCCGCCGGATGTCGGACGTCATCAGGGAGGTGAGTCCGGGCACGCGACTGTACGTCGACGCCAGCCACTACCTCGGCCTCGTCCTCGGCGGTCTCCTGGCCAACCCCCTGGACTGCGGGGCGGACGCCTTCGGCGGATCGACTCACAAGTCCTTCCCCGGGCCCCACAAGGGAGTGATCTTCACCAACGCCGAGGACGTCGACGAAAGCCTGCGATCAGCCCAGTTCGACCTGGTCAGCAGCCACCACTTCGCGGAGACGCTGGCGCTGTCCCTGGCGGCGCTGGAGGTCGAGGACCGGATGGGGGACTACGCCCGGGCGACGAACGACAACGCGCGACGGCTCGCCGGCGCTTTGGCCGACGCGGGGTTCCGGGTCTACGGCGACAGCGCCACCGGATACACCGACACGCACCAGGTCTGGGTGGAACTGGACGGTGTGGCAGCCGCCTACGCGCTGTCGAACCGGCTGGCCGAGGGGGGCATCAGGGTCAACCTCCAGTCGTCGATGCCGGGGATGTCCGGCGTGCACCTGCGCCTCGGCTCGAACGAGGTCACCTTCGAGGGCGCGGGCCCGCAGGCGATCGAAGAACTCGCGGGTGCCCTGGTCACGGCGAGAGAGCGAGCGCTCGGACCCCGCACCGTGCATGAGATCCGCGGGAGGTTCGGCGCCCCCTTCTACACCGATCCGGAGAAGCTGAAAGTGGAGGCCGGGCTGTGA	MTVGAGGKTSADADPLMLVRAIADADRRAAHALNLVPSENRISPLASLPLASDFYNRYFFNTDGDPLFWEFRGGEDIAHIEALGAAALRRMASARYCNVRPISGMSAMILTVAALSPPGSTVVSVDQNSGGHYATPALLGRLGRRSRLLNCKDGEVDESELAEVLAPGDVALVYVDVQNCVRVPDFRRMSDVIREVSPGTRLYVDASHYLGLVLGGLLANPLDCGADAFGGSTHKSFPGPHKGVIFTNAEDVDESLRSAQFDLVSSHHFAETLALSLAALEVEDRMGDYARATNDNARRLAGALADAGFRVYGDSATGYTDTHQVWVELDGVAAAYALSNRLAEGGIRVNLQSSMPGMSGVHLRLGSNEVTFEGAGPQAIEELAGALVTARERALGPRTVHEIRGRFGAPFYTDPEKLKVEAGL	MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRFLVLYGIAAPDSQRIAFYRLLDEFF	160.61	gnl|BL_ORD_ID|1912|hsp_num:0	2114			633	744	neomycin; ribostamycin; butirosin; kanamycin A; gentamicin B; paromomycin; gentamicin
BGC0000872.1|A-90289_14 # 13078 # 13956 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGGGG;rbs_spacer=10bp;gc_cont=0.683	BGC0000872.1|A-90289_14 	13078	13956	+	Loose	555	25.0238	OXA-457	26.32	3003613	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGCTGGGGCGGAACGTGGCCGATCGCTGTCCTCGACGTGTACGGGCGCGTGACATGCAACTGATGAAGTCGAGTTACCTGGAGCTGACCGCTCGCGGGCACGTGACCGACCTGCTGAAGCCCGACGACACCCTGGAGATGCTGGAGACCTACGGCTTCGCGGTGACGCAGAGCCCGGTTGAGGCCGTCTCGACGGCGCACGCCTACCGGGAGATAGCCGCGATACGTGAGGACTTCGGCCTGGGAGAGCCCTACGTCCCGCTGCTCTACCGGGACAGGGACGAGCCGACCGTCACCGCGGTGACCCGGAAAGGGGGCTCGGACCATCCGGTCTTCCACACCGGCGAGGCACAGGGCTGGCACACCGACGGGCTCCTGGAGGACATCGGGACCATCAAGACGACACTGCTGTACTGCGTGTCGCCGGCACACCGGGGTGGCAGGACGTTCCTGCTCAACGCGGGGCGGGTGTTCGAAGAACTGCGAATGGAGGATCCCGAGGCGGCCGACGTGCTGCTGCGGGACACGATCCTCGGTCGGCGGTCGACGATTCCCGGTGTGGACCGTGAGGCCGTCGGGCCCGTGTTCCTCGAACTCGGGGACGGCCACTACGCCACCCGATACGGCGAGGGACGGGTCGAGCGCTGGTACCCCGCGGACGCGGCCGAACAGCACGCGCTCGATCGCGCCCTGCGCTTCTTCCGCGCTCGCCGGGACGATCCCGACGTACGCATCGACCTGCTCCTGCGGGCGGGACAGTGCCTGATCTTCCGCAACGACGTGCTGGCCCACGGCCGGGAGAACTTCACCGACGACCCGCAGCGTCCCCGACTGCTCCTGCGCAGCCTGCACACGAACGCACCGAAGAAGCCCTCATGA	MLGRNVADRCPRRVRARDMQLMKSSYLELTARGHVTDLLKPDDTLEMLETYGFAVTQSPVEAVSTAHAYREIAAIREDFGLGEPYVPLLYRDRDEPTVTAVTRKGGSDHPVFHTGEAQGWHTDGLLEDIGTIKTTLLYCVSPAHRGGRTFLLNAGRVFEELRMEDPEAADVLLRDTILGRRSTIPGVDREAVGPVFLELGDGHYATRYGEGRVERWYPADAAEQHALDRALRFFRARRDDPDVRIDLLLRAGQCLIFRNDVLAHGRENFTDDPQRPRLLLRSLHTNAPKKPS	MTVRLFSTALGAALSLSALAGAPAQAAILCTVVADAADGRIVYQQGTQQACAARYTPASTFKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPVKAAAYDLAENLFEVGEASGWHLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVFARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK	106.18	gnl|BL_ORD_ID|2514|hsp_num:0	3524			573	795	cloxacillin; oxacillin; cefalotin
BGC0000872.1|A-90289_15 # 13953 # 14654 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.702	BGC0000872.1|A-90289_15 	13953	14654	+	Loose	650	29.261	adeL	36.59	3000620	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGGTGTCCGTCATCATCGCCATGGCGGGCGAGGGCACACGGTTCGGGGCCAGGTACCCGAAGGAACTGCACGCCCTGTGCCCGCACCGCACCGTGCTGCACTGCTGTGTCGCACCGCTCACCGAGCTCGATCCGGCGCGGCTGCGCATCATCGGTGTCGTCGGAGCGGGCAGAGCCCGTTCCATGGACGTGATCGAGGAAGAACTGGGCAAGCCCGGCGCGGAGGTGGTCTTCACCGCTCAGAACCCGCAGCGGCACGGGCCCGGCCTGGAGGGCGCCGTCCGCGCCGGTTTGCCGTTCTGCGAAGGGGTGACCGCCGTAGTGCTCGCGGACCAGATCTTCACCACCGAAAGGCCGGGGGACCTCACGAGGACGGTCGACGCGGCGCGACGGCACGGCCGGTCGGCGCTGGTTTATCCGACCACCGATCCCGAAGCGCTGCGCGCCGACGGCGCGGTGGCGTTCGACCGGCCCGCCGGCGTCATCACGCAGTGCGAGGAGAAACCGCAGGAGGACCTCGACAGGTTCGACGGCCTGTGGGTGGTCCCGATGGTCTCCCCCGAACACCGGGACGAGCTGCCGGCGATCGCCACCGATCCCGCACCGGTCCTGTCCGGTGCGAAGTACGTCGAGGTCGGCGACTACGTCAACGTGACGCGGCCGTCCGACGTCTGGGGCCGGCGATGCCCGGAGTGCTGA	MKVSVIIAMAGEGTRFGARYPKELHALCPHRTVLHCCVAPLTELDPARLRIIGVVGAGRARSMDVIEEELGKPGAEVVFTAQNPQRHGPGLEGAVRAGLPFCEGVTAVVLADQIFTTERPGDLTRTVDAARRHGRSALVYPTTDPEALRADGAVAFDRPAGVITQCEEKPQEDLDRFDGLWVVPMVSPEHRDELPAIATDPAPVLSGAKYVEVGDYVNVTRPSDVWGRRCPEC	MRVFNKVVETNSFSLAADSLGLPRASVTTTIQALEKHLQVRLLNRTTRKISLTPDGAVYYDRTARILADVADIESSFHDAERGPRGQLRIDVPVSIGRLILIPRLRDFHARYPDIDLVIGLNDRPVDLVGEAVDCAIRVGELKDSSLIARRIGTFQCATAASPIYLEKYGEPTSIEDLQKNHKAIHFFSSRTGRNFDWDFVVDDLIKSVSVRGRVSVNDGDAYIDLALQGFGIIQGPRYMLTNHLESGLLKEVLPQWTPAPMPISAVYLQNRHLSLKVKVFVDWVAELFAGCPLLGGTALPFDQKCEFACDKETGHEYTIRTLVEQHNIAEAYTLKT	69.14	gnl|BL_ORD_ID|2315|hsp_num:0	2654			78	201	tetracycline
BGC0000872.1|A-90289_17 # 15784 # 17058 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=AGGGGA;rbs_spacer=10bp;gc_cont=0.712	BGC0000872.1|A-90289_17 	15784	17058	+	Loose	275	28.4906	dfr22	31.06	3005354	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGAATTCCGGGGAAGAGACGGCTTCAGCCCTTGGACGGCCCTGGCGGGCTCCCCGAGATCATTCGGGCCCGACGTTCGTCACCGGGCGGGGCGCGTGGCTGGTCGACCGCAACGGACACCGGGTGATCGACGCGACGTCGGGCGCATTGAACGTGTTCTGCGGCCACGGCGTCGAGCGGGTGGTGGACGCCTATGCGTCGCAGCTGCGGACGCTGGCGCACGTCGACATGTCCCAAGGCCTCTCCGAACCCGCGCACCGGCTCGCGGACCGGCTGCGGGAGATCCCCGGACACGGCGACGACCGCTTCTTCTTCGGCAACAGCGGCTCGGAGGCGATCGAGCTCGCCGTCAAGATCTCCTCGCTGTACTGGTCCGCGGTCGACAGCCGGCGGACGGACATCGTCACCTTCGAGCCCGGCTACCACGGCTCGACCGCACTGTGCCAGTCGCTGTCCGGCTTGCCACAGACCAGCAGCACACCGGACCGGTGCGCAGGAAGCGTGCATCACCTCGACTTCGGGGAGTTCACCGGCCCCGGGCGGCGGTCGCCCGAGGCGCGGAGCCACATCGCCGGTCAACTGCGCGCGATCCTGGCCGGTTCAGCCGCGGGCACGGTGCTCGTGGAACCGTTCCTCAACGTCGGAGGCGGCATCCGGCTGCCCGAGGGACTGCTCGGCGACATCCGGCGCGTCTGCGACGAGTACGGCGCGCTGCTGGTACTGGACGAGGTGTTCACCGGTCTCGGCAGGACGGGGGCGTGGTTCGCCCAGGAGCACGAAGGCGTACGTGCCGACCTGACCGCCTTCAGCAAGGGCCTGACCAACGGCGTGTGCGCGCTGTCGGCCGTGGCGGTCGGCGAGCCGGTACTGGAGCGGCTCCCCACCGGGAGCGTCGTGACATACGGCCACACCATGTCGGCCTCGGCCGCCGCCTGTGCGGCGGCGAGTGCGACGCTGGAGCACATGAGTGCGACGGGAGCCGTCGCGGCGGCTCACGAGACCGGCGGCAGACTGCTCGGCGCGCTCGGCCGGGAACTGCGCGGCGCGGACGGCGTACTCGACGTCCGCGGGCACGGCCTGGCCCTGAGCGTCGAACTCGACAGCGCCCACATCGCCGGCAGCGTCCAGCACGTGGCCTACGACCTCGGCGCGTACACACGACAGCAGGGCAGAACCATCATGCTCGCGCCCCCCGCGTGTCTGAGCGGCGAGGAGGAGGACCGGCTCGCCGACCACGTGGTCACCGCGGTCCGCAAGGTGGTCGCCGCACGGTGA	MNSGEETASALGRPWRAPRDHSGPTFVTGRGAWLVDRNGHRVIDATSGALNVFCGHGVERVVDAYASQLRTLAHVDMSQGLSEPAHRLADRLREIPGHGDDRFFFGNSGSEAIELAVKISSLYWSAVDSRRTDIVTFEPGYHGSTALCQSLSGLPQTSSTPDRCAGSVHHLDFGEFTGPGRRSPEARSHIAGQLRAILAGSAAGTVLVEPFLNVGGGIRLPEGLLGDIRRVCDEYGALLVLDEVFTGLGRTGAWFAQEHEGVRADLTAFSKGLTNGVCALSAVAVGEPVLERLPTGSVVTYGHTMSASAAACAAASATLEHMSATGAVAAAHETGGRLLGALGRELRGADGVLDVRGHGLALSVELDSAHIAGSVQHVAYDLGAYTRQQGRTIMLAPPACLSGEEEDRLADHVVTAVRKVVAAR	MNPELVRIYLVAAMGANRVIGNGPDIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPLPNRRTVVLSRQASYSAAGCAVVSTLSQAIAIAAEHGKELYVAGGAEVYALALPRADGVFLSEVHQTFEGDAFFPVLDEAEFEVVSAETVQATITYTHSVYARRNG	256.97	gnl|BL_ORD_ID|3058|hsp_num:0	4085			117	495	trimethoprim
BGC0000872.1|A-90289_19 # 18429 # 19493 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGGGA;rbs_spacer=6bp;gc_cont=0.681	BGC0000872.1|A-90289_19 	18429	19493	+	Loose	650	33.113	ALG6-1	28.7	3006893	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ALG6 beta-lactamases	ATGTCTAGTGGGATCACCGCGCCTGCGTCCGAACAGGCGGTGCGGCAGCACCTGTCGGAGATGCTCCGCTGGCACTTCGACAAGGAGACGGGCTCGCCGTTCTGGGTCGGGCACCGCGAGGCGCTGCCCTTCGACCCGGTCGCCGACATTCACACCTTCGATGATCTCAGGCGGTTCCCCTCCCGGGTGAACGAGCTGCGCACGACACGGGTCGAGGACCTGGTTCCGCGAGGACTGGCCCACGAACCCCCGCCCAGCGTGGTCGAGTCAGGCGGTACGACCGGCAGCCCGAAGCGGGCCGTCCTGTCGCACACCCGCATGGAGCAGCTGGTCGACATGTACTGCGCGTACGTGCCGGAGGCCGAGGGACACACCATGCTGTCGCTGTTTCCGAGCGGTCCCCATCTCGCGGGGAACTGGCAGCGACGATGGGCGCGTCGGCTGGGCGTGCTCTACCTCCAGGTGGACATCGATCCGCGGTGGGTGAAGTCCGGGATCGGCACGGACCTCCAGGAGCGCTACACGCACCACGTCCTGGCCCAGGCCCGGGACGTGCTCCGGACGCAGCGGGTCGGACACCTGTTGGTCACCCCTCCGTTGCTTCGCCGGATCGCACGGTCGAAGGAGCTGGCGGAACTGGTGCGTGCCACCGTCCGGGTCATCACCTGGGGCGGCGCACGCATGACGCGGGAGGAACTGTACGAGTACGCGCACCTGGTGTTTCCCGAGGCCGGCTTCTTCGCCACCTACGCGAGTTCGATCACGGGCACCCGGGCACTGCTCAGGAGATCGACGGCTGCCGACGATCTTCCGGTGTTCGATCCGGTAGGTCCCGAACTGTTCGTCCGCGTGGTCGACCCTCACACACGCGAGCCCGTGCCGTACGGCGCCCGCGGGCAGGTGCTGATGCACACGGTCACGCGGGACATGTTCCTGCCCAACAACCTGGAACGGGATCTGGCCGTGCGCGTGTCGCGGGGCGAGGACTGGCTCGGCGACTCGCTCGCGGACGTCGTCCCGCTGTCGGAGTTCGAAGGCAGTCGGGTAGTCGAGGGGATCTACTGA	MSSGITAPASEQAVRQHLSEMLRWHFDKETGSPFWVGHREALPFDPVADIHTFDDLRRFPSRVNELRTTRVEDLVPRGLAHEPPPSVVESGGTTGSPKRAVLSHTRMEQLVDMYCAYVPEAEGHTMLSLFPSGPHLAGNWQRRWARRLGVLYLQVDIDPRWVKSGIGTDLQERYTHHVLAQARDVLRTQRVGHLLVTPPLLRRIARSKELAELVRATVRVITWGGARMTREELYEYAHLVFPEAGFFATYASSITGTRALLRRSTAADDLPVFDPVGPELFVRVVDPHTREPVPYGARGQVLMHTVTRDMFLPNNLERDLAVRVSRGEDWLGDSLADVVPLSEFEGSRVVEGIY	MSHGIPCAPSSRMETQMVSKMAMAAILLLAGPTAAAEVTPTTPIVCSMCEGWNRPQKPFKIYGNTWYVGTNDLSALLVTSPNGHVLLDGALPQSAPLIEANIQALGFKLKDVKLILNSHEHFDHAGGIPALQRASGATVAASIRGAKVLRAGTVGKDDPQFDPVKPFFLAKLEKVREVADGETLTAGDLRITAHYTPGHTPGGTSWTWTSCENGRCLNMVYADSLTPVSSEGFRFSGGNGAPDISSAFQATIDKVAALKCDVMVSNHPGFSQVMEKLAARTDANNTFIDPTGCRKYAAAASKRLANRLATEAKQKAAR	111.32	gnl|BL_ORD_ID|3290|hsp_num:0	4359			225	516	
BGC0000872.1|A-90289_20 # 19493 # 20971 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=AGGGGA;rbs_spacer=7bp;gc_cont=0.714	BGC0000872.1|A-90289_20 	19493	20971	+	Loose	500	25.7942	AAC(3)-IIg	36.36	3005085	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGGCGAACGCCCGGGACGGACAGAAGGTCCCCGTCGTCCGGACGACCACGGCCGGCGAGGTCGGCGGGGTGCAGTACCGGCCGTCGGGCCTTGCCGTGTGGCGGGGCATTCCCTACGGCACGGTCCCGGCCGACGGCGGCAGGTTCGCCGGGCCGTCGCGGCCACGCCCGTGGGACCGTGTGCGGCCGGCGTTGCGCCACGGCAGCATGTCCTGGCAGCTGCCGCCGGTCCACGACAGGTCCTGCGACGTCATGCGGGAGTTCGACTTCGCCCACACCGCCGACCCGGAGCACGAAGACTGCCTGAACCTCAACGTGTACACACCGGACCCCGGACGCGCCGGTCTGCCCGTTCTCGTCTGGTTCCACCCGGGCATGCAGGTCGCCGGGTCGGGCAACATGCCCGGCAGGCGCCCGGAGGTCCTCAGCCGCAACCACGGCGTCGTGGTGGTCACCATGAACTTCCGGCTGGGATGCTGGGGCCATCTCTTCCTGGACGACCTGCTCGGACGCGACAGCGCCAACCTCAGGCTGCGGGACCAACTCCTCGCTCTGACCTGGGTGAAGGAGAACATCACGGCCTTCGGCGGCGACGAAGGCAATGTCACGGTGTTCGGGGAATCCGCGGGAGCACGCAACATCGGGTCCCTGCTGGGATGCGCGGCCGCCGACGGCCTCTTCGAACGGGCCGCCCTGTACAGCGGCGGCTGCGAGAACACGGTGTCGCGAGCCGAGGCGACCGATCTCGCCCGGGAGTTCCTCGACTGCGCCGGGCTGACCGGCGATCCCGCACGGGTCCTGACCGTCCCGAACGTGCACCTGAAGGTGGCGCACGAACGCCTGCTCAGACGCCACGAGATCGTGCACTACCGGGACGTGGTGGACGGCGTGCACCTGCCCCGCCCCCCGGTTGAGGCCATCGCGGCGGGCACGGCCTCCGGCAAGATCGACCTCCTGGTGTCCAACTGCGCGAACGAGGCCGGCCTGTGGGACCGTCTGATGCCGGGCGGGGCGCGCGTGGTGGCTCAGGGGGCGAGGGCGACGGGAGCACGAATCGCGTGGTACGGAACCGATCACGAGCGGTTCATCAACGAGGAGTTGTTCCTGCGCCCGGCCCGCGACCTGCTCCGAGCGAAGGCCGCGGCGGGTGGTGGCCGGTGCTGGTACCAGGTGTACGACTACGTCCCCTCGAACCACAGCTTCGCCGACGCTGAGCGTGCGCTGCACGGCATGGACCTCGCGTCCCTGCTGCTCGACCTCTCCGCACCCGGCACCGCATCGGAGGCCGACGTCGCCGTCGCCCGCACCGTCCAGTCGGCGCTCGTGGACTTCGCGAGCGGGCGGGTGCCGACGACCGACGGCCTCACCTGGCCACGGTACGAGACGGGCGCGGAGCGGTTCGTCCGCATCCGGCGCAGTCCGCACGTGGAAGCGGCAGCCTGGCCGCTGGACGACGACACCGCGGCAGCGGACCGGTAG	MANARDGQKVPVVRTTTAGEVGGVQYRPSGLAVWRGIPYGTVPADGGRFAGPSRPRPWDRVRPALRHGSMSWQLPPVHDRSCDVMREFDFAHTADPEHEDCLNLNVYTPDPGRAGLPVLVWFHPGMQVAGSGNMPGRRPEVLSRNHGVVVVTMNFRLGCWGHLFLDDLLGRDSANLRLRDQLLALTWVKENITAFGGDEGNVTVFGESAGARNIGSLLGCAAADGLFERAALYSGGCENTVSRAEATDLAREFLDCAGLTGDPARVLTVPNVHLKVAHERLLRRHEIVHYRDVVDGVHLPRPPVEAIAAGTASGKIDLLVSNCANEAGLWDRLMPGGARVVAQGARATGARIAWYGTDHERFINEELFLRPARDLLRAKAAAGGGRCWYQVYDYVPSNHSFADAERALHGMDLASLLLDLSAPGTASEADVAVARTVQSALVDFASGRVPTTDGLTWPRYETGAERFVRIRRSPHVEAAAWPLDDDTAAADR	MNTRETIAADLSRLGVQSGALVMVHASLKAIGPVDGGAASIVSALLDAVGPTGSLMGYASWDRSPYEETLNGARMDAELRHRWPPFDPAISGTYRGFGLLNRFLLQTPGARRSAHPDASMVAVGPLAGTLTRPHELGQAFGPGSPLERFVERAGKVLLLGAPLDSVTVLHYAEAIARIPNKRRVSYEMPIRSEDGGVRWKRAEDFDSNGILDCFAIEGEPDAVETITNAYVELRRHREGLVGQAHCYLFEARDIVSFGVDYLQRHFGSP	182.90	gnl|BL_ORD_ID|2801|hsp_num:0	3820			597	708	dibekacin; sisomicin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
BGC0000872.1|A-90289_21 # 20989 # 24702 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.715	BGC0000872.1|A-90289_21 	20989	24702	+	Loose	1100	258.455	tetB(60)	28.87	3004036	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGTGAGCACGGAACTGCGGACGTCGCCTTCATGGGCGCTACGGCTGATCGTGTCCTGGGCCACCGACCGCCGGGCCGCGGTCGGAGCCGTGACCCTCGCACTGGCCGGTGCCGCAACGGACCTCGCCACGCCGCTGTTGATCAGGTCCGTGGTCGACGGACTGTCCGCCGGCCGGTCGGTCGCCACCGGCGCGCTCGTCCTGCTCACGGTCGCCGCCCTCCTCAGGTTCGCCGTCCAGTTCGGCCAGCGCACGACGGCGAGCCGGCTGGCGAACCGGGTGCAGCACGAGCTGCGCGTGGCGCTGCTTTCCTCGGTGTGCCGCTATTCCGGCCAACGGCAGGACGCCGTACGGCGGGGTGAGGTGGTATCCCGGTCGGTAGCCGATCTGCAGGTGGTCCAGTCGCTGCTCGCGCTGGCCCCGCAGGCTGCTGCCGCGGTGCTGCACGTCGTGATCCAGATGGTGATCATGTTCGTTCTCTCTCCGGTGCTCGCCCTGGCCACGCTGGTCACCATCCCCCTCGCGGGCGCGCTGGTGGTCCGCTCACGTCGGCGGCTCTACGCGGCCACGTGGCTTTCCCAGCAGGCGACCGCCGACGTGACCTCGTTCACCGGAGAGGCGATAGCCGGACTTCCCGTCACGAAGGTCTTCGGGCGTGAGGAGTTGATCGAGCGGCGCTTCCTCGACCTGGCCCGCGACCTGTACGGCAAGCGCCAGCGGGTCGCCCGGCTGAACGCCGCGTTCGGCCCGGGCCTGGCTGTGCTGCCGCAGTTCGCGCTCGTCCTGGTCATCGGGGTCGGCGGGGCGATGACGCTGCGCGGCGAGATCAGCGTCGGCACGTTCATCGTGTTCGCCGCCTACCTGCTCACCATGACCGGTCTCATTCGGCTGCTGGCGGGAGTGATCTCCGCTGTCGCGCTCGCCAGGTCGTCCGTCGAGCGGATCCACGCGATCATCGACAGCGCCGAGCGCGTGCCGGAGCCCCCCGCCGCGGGACCCCGGACGAACCGGGGTGAGGGGCTCGGCCTGCAGCTCTCCGATGTCGGGCTGACACTCGGGCCGGACGGGCGAGACGTGCTGCGGGGGGTGAGCATCGAGGTCTCGCCCGGGGAGTGCCTCGGTGTCGTGGGCAGGGCCGGTTCCGGGAAGTCGGTCCTCGGCCTCGTGCTCCAGGGGCAGTACCGGCCCAGTGCCGGGCGCGTCGAACTCATCGGCTCGCACGGCCGCTTCGGCGGCGAGGACGACTCCGGGACGGTGGCCCCGGGCGACCCGGACGTCGTGCTCTTGACGGAGGAACCGTTCCTCTTCTCCGGCACCGTCCGGGACAACGTCCTCCTCGGCAGGAAGTTCGACGCGGACCGGTATGCGTCCGCTCTCACCGACGCGGCCGTGGACCCGATGCTCGAGCGCATGGCGGACGGGGACCGGACCTCCGTGGGCGAGGGCGGGGCCTGGCTCTCCGGCGGTGAGCGGCAACGGATCGCGCTCGCCCGGGCCTTGTACAACTCGCCGCGCCTGCTGGTGCTGGACGACGCTACGTCCGCTCTGGACACTCTGACGGAGGCGAGGGTGTTCGACGCGCTGCGGCGGCGGCTCGGCCGCGGCTGCACCATGGTCGTGACCGGCCGGCGGCGGGCCGTGCTGTCCCTCGCCGACCGGATCGCCGTCGTCGAGGGCGGCCGGATAGTCGAGCAGGGCGACGCACGGGAACTCCTGCGCTGCTCCGTGCGGCTGAAAACCCTGATGGGTGAAGACACACCGACCCCGACGCTGGGCGCCGACGAGGTCGCGAGCGGTGAGTCGCAGGTGCACGGGACACCTCCTCAAGACGCCGGACCTGGAGCGGCGGGAGCCGGCGAGGAGGACCCCGCAGCGGTGCTCGCGAAGTACGTCGCCGAGCTGCCCCCCGTCGTCGACGTGCCCCAGCGCGCCGATGTCGCAAGCGGCCGGCACAGCGGCCCGTTCGGTCTGCGGAAGGCGCTGCTGCCGGTCCGGCCGGCGGCCGTCACGGCACTGGTGTGCATCACGATCGAGGTCGTCGCGGCCGTGGCACTTCCCGCGGTGGCACGGGCCGTCCTCGGGCGCTCGACGGACGGTGACGCCACGGCTGTCGGGCTGCTGTTCACACTGGGGCTCGCGATCACGGCGGTGAGCTGGATCGCGGGGTGGGGGACGGTCCGCGCGACCACACGGGTGTGCGACCGGGTCCTGTTCGCCGTCCGCCTGCGGTGCTTCCGCCACATCCAGCGTCTGCCCCTGAGCTTCGTGGACCGGGCCCGGTCGGGGAACCTGCTGACCCGGATGACGGCCGACGTCGACTCGCTGTCCGCGTTCCTCCAGACCGGTCTGCTGTCCCTGATCGTCAACCTGCAACTGCTGCTCGGTGTGGCCCTGATGGTGGTCCTGCTGGTCCCCGGCTCCTGGCCGGCCCTGACAGCGGCGGCGCTTGTGGTGTTCGCAGGGGCCGTCGCGTTCCGGAGGATCGTCTCCCGTTCGTACCCGAGGGCGAGGGAACTGCTCGCCGCTGTCAACGCCGACCTGCACGAGAAGGTGCACGGAGTACGCACGGCGCAGATCTTCCGCTGCACCGACCGGCTCATCGCCGAATTCGCGCAGAGGTCGGCGGCCTACCGCGACGAGCGCCAGGCCGGACACCGCGCGGTGGCCTGGTTCTTCCCCCTGGTGGCGCTGGCCATCGACATGGCGCTGATCTGCGTGCTGCTGCCGACTGCCGTGGCCGCAGTGCCCTGGAAGGTCAGTGACGACGGGGGCACGATCGCCGCGCTCGTCCTGTACCTGTCCATGCTGTACTACCCGATCCAGCAGATGGCGACGGTCTACGACAGTGCCCAGCAAGCCGGGGTGGGACTTCACCGCATCAACGGCCTGCTGGCGCAACCCGTGGAGGACGAATTCGACGGCGCCGGGGCCGGCCTGCCGAGCACCGGCGGAGCCCTCCGGTTCGACCGGGTCGGTTTCACCTACCGGCGGGACGCCCCGTACTCGCTCCTGGACGTCGTCCTCGACATCCGTCCGGGGCAGTCCCTCGCCGTCGTGGGCCCCACGGGCGCGGGGAAGTCGACGATCGTCAAGCTGCTGGCACGCTTCTACCGACCGCAGCGGGGTGCCATTCGCCTCGACGGCGTGGACATCGCGACGATTCCGCTGCGCGACTACCGCCGGCGGGCCGCCCTCGTGCCGCAGGAGGCACATCTGTTCAGCGGCTCCGTCGGCGAGAACATCGCGTTCGGCCGTCCGGGTGTGTCACGGGCGGAGATCATGCGGACAGTCCGCGCGTTCGGCGCGTCGGAGATGATCGCCTCCCTGCCCGGCGGACTGGACTACGACGTCGGCCCGCGAGGCTCGGCGTTGTCCGCAGGACAGCGGCAGGTGGTCGCCCTGCTGCGGGCGATCGTGTCGGATCCGGACCTCCTCCTGCTGGACGAGGCGACCTGCGCGCTCGACCTGGAGGCCGAGCGGAGCATCGTCAACGCGCTCCGTGAGGGCGAGGGCGGGCGCAAGACCGTCGTGGTCGCGCATCGCCTTGCCACCGCCGCCCAGGCCGACGTCATCGCCGTCGTCGAACGGGGCCGGCTGCTGGAGTCGGGCGGCCACGAGGCCCTGCTGAGGTCGGACGGACTCTACGCCGACCTGTGGGCCGCCTCCGAACACGACGGAGCAACGAGCAACCGAGGACAAGGAGACAGTGCGTGA	MVSTELRTSPSWALRLIVSWATDRRAAVGAVTLALAGAATDLATPLLIRSVVDGLSAGRSVATGALVLLTVAALLRFAVQFGQRTTASRLANRVQHELRVALLSSVCRYSGQRQDAVRRGEVVSRSVADLQVVQSLLALAPQAAAAVLHVVIQMVIMFVLSPVLALATLVTIPLAGALVVRSRRRLYAATWLSQQATADVTSFTGEAIAGLPVTKVFGREELIERRFLDLARDLYGKRQRVARLNAAFGPGLAVLPQFALVLVIGVGGAMTLRGEISVGTFIVFAAYLLTMTGLIRLLAGVISAVALARSSVERIHAIIDSAERVPEPPAAGPRTNRGEGLGLQLSDVGLTLGPDGRDVLRGVSIEVSPGECLGVVGRAGSGKSVLGLVLQGQYRPSAGRVELIGSHGRFGGEDDSGTVAPGDPDVVLLTEEPFLFSGTVRDNVLLGRKFDADRYASALTDAAVDPMLERMADGDRTSVGEGGAWLSGGERQRIALARALYNSPRLLVLDDATSALDTLTEARVFDALRRRLGRGCTMVVTGRRRAVLSLADRIAVVEGGRIVEQGDARELLRCSVRLKTLMGEDTPTPTLGADEVASGESQVHGTPPQDAGPGAAGAGEEDPAAVLAKYVAELPPVVDVPQRADVASGRHSGPFGLRKALLPVRPAAVTALVCITIEVVAAVALPAVARAVLGRSTDGDATAVGLLFTLGLAITAVSWIAGWGTVRATTRVCDRVLFAVRLRCFRHIQRLPLSFVDRARSGNLLTRMTADVDSLSAFLQTGLLSLIVNLQLLLGVALMVVLLVPGSWPALTAAALVVFAGAVAFRRIVSRSYPRARELLAAVNADLHEKVHGVRTAQIFRCTDRLIAEFAQRSAAYRDERQAGHRAVAWFFPLVALAIDMALICVLLPTAVAAVPWKVSDDGGTIAALVLYLSMLYYPIQQMATVYDSAQQAGVGLHRINGLLAQPVEDEFDGAGAGLPSTGGALRFDRVGFTYRRDAPYSLLDVVLDIRPGQSLAVVGPTGAGKSTIVKLLARFYRPQRGAIRLDGVDIATIPLRDYRRRAALVPQEAHLFSGSVGENIAFGRPGVSRAEIMRTVRAFGASEMIASLPGGLDYDVGPRGSALSAGQRQVVALLRAIVSDPDLLLLDEATCALDLEAERSIVNALREGEGGRKTVVVAHRLATAAQADVIAVVERGRLLESGGHEALLRSDGLYADLWAASEHDGATSNRGQGDSA	MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGGLLLWVGIYVTVNLVGVAGAYLNRVYMKTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGKVVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQRTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQQEEKIVAEYDATATSWVEVGRKELILESYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQTFMNVVSGFQQSMAAGDRVFELMDTPSEESGEELFTFDEGCIEFKDVSFEYTAGVPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGIVLQDPYLFTGTIASNVGLNNESIEPETIKEAIIKVGGGHLLTKSDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG	213.64	gnl|BL_ORD_ID|2307|hsp_num:0	2646			42	1725	tetracycline
BGC0000872.1|A-90289_22 # 24699 # 25733 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.676	BGC0000872.1|A-90289_22 	24699	25733	+	Loose	950	27.335	fusH	40.0	3003026	protein homolog model	n/a	n/a	fusidane antibiotic	antibiotic inactivation	fusidic acid inactivation enzyme	GTGAAGTCTTTGACGTGCGGCGAGGAATTCAGGTTCAACGGGGTGGTCTCGTTGCAGCAGGGCGAGAACTGGCTCGCGCCGTGGCGGGTGCCGTTCGACGAGGCCCGCCTGTACTTCCCGGAAGGCGGCATCGGTCGGGCAGCCATGCCGTCCGGGGTGTCCATCGCGCTGGTGACGGATGCCGCGCACATCGAAATGGACTACCTGTGCTCGCGGTGCCCGGACAACATCATCGAACTCGCCGAGGACGTGCAGCAGCTGGAATCCGTCGACGTGGTGGTGAACGGCCGCCGCCTGGGACGGCACGCCCTGTCCGCCCTGAAGACCCAGAAGACCCTGCGACTGGACCTCGGTGACGCGGGCGGCGGCAGCCGGCTGGTCGAGATCTGGCTGCCGCTCTACGCCCAGTTCCGATTGATCGACCTGCGGGTCGAGGAGAGCGCGAACGCATCATCGCCCGTCCCGAACCCCAGGCGGTGGGTGCACTACGGCGGCTCCCTGTCGCAGGGCATGGGGGCGGATTCGCCGCTGACCAACTACGTCCAGTCGAGCCGGTGGCGCACCGACCTCGACCTGGTGTCGGTGGCCCGGGGAAAGGGCACGCACATGGAACCGCTGTTCGCGGATCTGATCGCCGGCCTGCGACCGCGGTACGTGACGATGGCGGTCGGCGGAATGATCTACCTCACCGGGTCCCTCAATCAGTACACCTACCTCACCAACCTGCTCGGGTTCGTGAAACGCATCATCGATGCCGTGCCGGACTGCGAGGTGGTGGTGATCGTGCCGCCGATGAGCCCCCGGTACCGCGACCTCAAGGGCCCCGGCGGGATGACCGCGGCGGAGATGGTCGAGATGCACTACGCCGCCGTCGAGACGGTGATGAAGTGGGGCGACAAGAGGGTTCACCAGGTGCGCCAGTGGGCGGACGCCGACGAGCCCGACTTCCTCGCCGACGGCATCCACCTGACGTCGAGCGCGCACCGCCGGTACGGGCAGTACCTGGCGCGCGAGATCCGGGAGTGCGTCGGATAG	MKSLTCGEEFRFNGVVSLQQGENWLAPWRVPFDEARLYFPEGGIGRAAMPSGVSIALVTDAAHIEMDYLCSRCPDNIIELAEDVQQLESVDVVVNGRRLGRHALSALKTQKTLRLDLGDAGGGSRLVEIWLPLYAQFRLIDLRVEESANASSPVPNPRRWVHYGGSLSQGMGADSPLTNYVQSSRWRTDLDLVSVARGKGTHMEPLFADLIAGLRPRYVTMAVGGMIYLTGSLNQYTYLTNLLGFVKRIIDAVPDCEVVVIVPPMSPRYRDLKGPGGMTAAEMVEMHYAAVETVMKWGDKRVHQVRQWADADEPDFLADGIHLTSSAHRRYGQYLAREIRECVG	MLNKGIRTRRARGALAGGTVLTAAAALLTAVPAAQAISGEPPAATDHAFTARLHIGEGDTLRGCSAALVHQQWLLTATSCFAATPGGEVKSGKPALKSTATLGGKTLGIVEVVPRDDRDVAMVRLAEPVTTVEPVRLAADAPVAAETLLGAGFGRTRTEWAPDQLHTGEFRVDSVTGTTVELTGQDGVSVCKGDTGGPALRGTGGEVELAAVHSRSWQGGCFGETETRTGAVDARADGLADWVTDVRNRDRTQSADVDGDGRADLVVLRSNGDVVVHRNLGDSFAAGRVMSGGWGLFVTWKDLGRLYFADVDGDRKADMIVHTSDGNIEVRFNHGTYWDQGTHWSGGWGRFIDGSDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVTWKDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVDGSDLGSLEFGDATGDGKADLLVRTKDGKVALRTNHGTYWDQGKFMITL	67.58	gnl|BL_ORD_ID|65|hsp_num:0	75			984	1119	fusidic acid
BGC0000872.1|A-90289_23 # 25837 # 26034 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.702	BGC0000872.1|A-90289_23 	25837	26034	+	Loose	730	23.0978	farA	31.37	3003961	protein homolog model	n/a	n/a	antibacterial free fatty acids	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCAGGACGCGGAGCACGTACAGGGCGACGAGCCGGGCGAGTCGGCCGCGCCGGCTCAGGAGACCGGATCGGCACAGACGACGGGACCGGCCGACAAGGCAGCCGCGGAGGATCCCGATTGGTTCGAGGACGTACCCGAGGAGAACGTCGGGGCCGTGCTGTCCCTGGACGAAATAGCCCCGCACCCGGGGATCTAG	MQDAEHVQGDEPGESAAPAQETGSAQTTGPADKAAAEDPDWFEDVPEENVGAVLSLDEIAPHPGI	MDTHTDETKLQNTQAKRKRRLTALTLLFALAAAAAGSAFFLWWQHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDTSAAGAPVSKTPGAALPEMESTDWSEVDRTVDEILGQSAP	16.93	gnl|BL_ORD_ID|2189|hsp_num:0	2428			852	996	palmitic acid; oleic acid; linoleic acid
BGC0000872.1|A-90289_24 # 26039 # 27841 # 1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=GGGGA;rbs_spacer=9bp;gc_cont=0.713	BGC0000872.1|A-90289_24 	26039	27841	+	Loose	250	25.409	arr-1	33.33	3002846	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	GTGGACAGTGCCGTGGGCTCTTCTCGACCGTCAGCCGTCGTCCAGGTCGACGACAGACAGCGGGACGTGTTGCGGTGGTACGCCTCGCTGTCGAGCGCTGCCGAGGCCGACCGGGCGTGGCCCGAGGGCGCAGTGATCGTTCTGCACGGCGATCTCACGCCGGACGAGGGCGAGCTCGCCCTGCTCGGATGCCGCACGGTCACGGAGGTCTCCGCCGATGACGTGCGTCACGGTACCGCCGAGCGGTCGATACCGGCGTCGGCGCGGTACGTCCTGGTGGTCGCCGCCCGTGAGGAGTTCGACCTGCGTCTTGCTCGCGACATCGTGGCGTTCGGGCGCCGGATCGGCCTGCCCGTGGGCACGCTGCCGGCCCGCTCCACCGGGGAACTGGGCTTCATGCTGAGGCGTATGGCCCTGGCACGACGTGCGCGGCCGGGCCGGCACGTCGTCGTCGACGCCGCCGATTCGTCCTCCGTCGCGGGCGACGCGGCACAGTTCGCGGACCCCGGGGCGCGGGAAGTGCACAGCGTCTCCGTGTACGGACACGGCAACGAGTCCCACGTCAAGATCGGGGAGAAGTTCATCTGCTCCCACGGAGTGGACCGCTTCCCCGAGCAGGACTGCGCCTGCGCCGAGCACGGTCTCAGGCTGTGCAGGCTCGACGAGATCCGCTGCGTGTGGATCCACCTGGGATCGTGCGGGGCGCTGATACCCGACTGGCGGCGCAGCGTGCCCGCGTCCAACTTCGTCGACGCCTTCGCGAGTTCGTACGCGGCGACGGTGTGCGGGTCGCTCTACCGAATGCCGACCTCCCGTGCGGCCATCGTCACCCATGAGCTGAATCGGCTGGCCGGCTCCGCGCCGGGCGGGGACGACCCCTCGGCGGGCACCCTCTGCCTGGGCGACCCGGTCCTGTTGGCGCACACCGGCGCCGTCCTCGACAAGCAGGCGGTCGTCACTGGCCTGCGGGCCGAACTCGACGCCGTTGCTTCCCGGTCCGCGCGCTGGTCTCAGGACCAGGAGCGGCTGCGCACGCTGACACGCACCCTCCACGACGCGCGTGAGGAGCTCACCGCGCTGCGCCTGGCGGGCGGGCCCGCCTCACGCGGGGGGCCGCCCGCCGGCGTGGGCTGGATCGACAGTGCCTCGGGCTGGGCGGCCCGAACCGCGAGAGTGCTGTCGGCGGCCCATGAACGTCAGCTCTACGACGAGACCGCGCGTGCCGAAGTCAACCGTTGTCTCACCAAGACCGAGGATCTCGCCCGCCGGTTCGAACAGGACCTGGTTCCGTTCGTGGCGTCGGTCCCCGCCGTGGGGGCCCGCGATGTCGAACGCGCCATGAAGAGCGGACTGATCTTCGGAGCGAAGCGGCCGGGAGAACTGTGCACCTGCCGGCTGTGCGGGCTCCCTGTGTACGTCACCACCGCCCGGAACGTGGCGAGTGACCGAGAGAGCTTCTGGGCGCAGTGCGACGTGTGCGGGCACCTGGCGAGATCGCCTGACGCGGTGCGCTTCCCGTTGATCACCGTTCCCGCACCGGGTGTCGTCGGTGTCCGGTTCTTCGGCATCAACCGAACGGACCCCACAGCCCGGGTGATCGTCGACATCGACGACGGCGTCGGGACCCTGCACACCCGGACCGTGCACGAGATCGCAGGCGGTGAGGAGGCTCGCGTGCGCTGTGACCCCATGGGGTCCGGGCCCTCGCTGCGGGTGCGGGCGCTGGTCGTGTCCGGGTTCGCGATGTGGTTCGCGCGCGCGACCGTGCCGTCGGCCCGACTGCTCGGCCCGCCGCCGCCCTGA	MDSAVGSSRPSAVVQVDDRQRDVLRWYASLSSAAEADRAWPEGAVIVLHGDLTPDEGELALLGCRTVTEVSADDVRHGTAERSIPASARYVLVVAAREEFDLRLARDIVAFGRRIGLPVGTLPARSTGELGFMLRRMALARRARPGRHVVVDAADSSSVAGDAAQFADPGAREVHSVSVYGHGNESHVKIGEKFICSHGVDRFPEQDCACAEHGLRLCRLDEIRCVWIHLGSCGALIPDWRRSVPASNFVDAFASSYAATVCGSLYRMPTSRAAIVTHELNRLAGSAPGGDDPSAGTLCLGDPVLLAHTGAVLDKQAVVTGLRAELDAVASRSARWSQDQERLRTLTRTLHDAREELTALRLAGGPASRGGPPAGVGWIDSASGWAARTARVLSAAHERQLYDETARAEVNRCLTKTEDLARRFEQDLVPFVASVPAVGARDVERAMKSGLIFGAKRPGELCTCRLCGLPVYVTTARNVASDRESFWAQCDVCGHLARSPDAVRFPLITVPAPGVVGVRFFGINRTDPTARVIVDIDDGVGTLHTRTVHEIAGGEEARVRCDPMGSGPSLRVRALVVSGFAMWFARATVPSARLLGPPPP	MVANPPKPFEVHESGAYLHGTKADLKVGDRLVPGRESNFEAGRIMKHVYITQTLDAAVWGAELAVGEGRGRIYIVEPEGEIEDDPNVTDKKLPGNPTRSYRTREPVRIVGELTDWEGHSPEQIAAMREGLEDLRRKGLAVIYD	419.58	gnl|BL_ORD_ID|1801|hsp_num:0	1950			15	96	rifampin; rifaximin; rifabutin; rifapentine
BGC0000872.1|A-90289_25 # 27885 # 28061 # -1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.695	BGC0000872.1|A-90289_25 	27885	28061	-	Loose	1700	21.9422	LpeB	42.11	3004100	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGATTCAAGGACGCCGCCCGCACTCGGACCCGGACCCAGCCGTGCGGCACCTGGGGATCGGGGCGGTGGCCGACGGCGACAGCGGACAGCGGGTCGTCTGGCTCGGGGGAGGTCGCGAACACTGCTTTCATGAGTCGTCGTCCTCGGGCTGCCGGATCGCGTTCCCACGCATGTGA	MIQGRRPHSDPDPAVRHLGIGAVADGDSGQRVVWLGGGREHCFHESSSSGCRIAFPRM	MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVETAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLPPEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQPYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENLLIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVIKGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLITIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAALKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPLMCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLISHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIVLPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTPDHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTIEVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPATLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSMLFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLITLIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHDAGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE	5.72	gnl|BL_ORD_ID|2387|hsp_num:0	2759			2466	2517	erythromycin; spiramycin; azithromycin
BGC0000872.1|A-90289_27 # 28991 # 30253 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.697	BGC0000872.1|A-90289_27 	28991	30253	+	Loose	400	29.261	ErmS	28.12	3001304	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGATCCCCGACAGGTCGAAACCTCCGTCGCGGACGAGCACCGCGATCGATCTCGTGCGTGAGACGGGGGACGTCACCGATCTTCCCGCGTGCGACAGCCGATTTCATTACGTTCCGCCGTGGCGGGTCGCCGCCCTGGAAACGCTCGCCGAGAAGGTCCTCCCCCCGGTCGCGGACCTGGCGGCACGGTACTCGGCCGCCGGCCGGATGGAGGACCTGATCACCGCGGACGAGACGGCGACACTGATGGACGCGTGCGCCTTCGTACGGTTACGCGGCGCGAGGGACGGCTGCACCCTCGCTTTCGGTGGCCTGCCCCCGGAGCTGACGGAGTACGGGCGGCGCGAGCGGATGACGGTCCGTGCGGCCCTTGAGTGCGTCGGCTGGTTCGACGCCAACCAGCGGCACCTCACCACCGTCGACATCGCACCGGGGCGACCCGCCGGAGCGCAGCCTGTCGACGGTGCGCTCTACGGAGCGGAGCTGGCGCGCCGCTACGACCCGGCACGGCAGGTGACCGAGCGGTTCAACGACGTGCTGCGGGCGTTCGCCAAGGAGTTCCTCGGGACGCGTCGCGTCCTGGAACTGGGCGCCGGTACCGGGAGAGTGGGACGCAACATCGCCCCCTTCGCCGGCTCCTACGCGGGGATCGAGGCATCACACGCGATGATCTCCGCGGGACGCCGGTACGGTCTGGACGTGCGGCACGGGGACATGATGGCGATGCCGTTCGAAACGGGGTCGTTCGACGCGGTCGTCGAGCACGAGAGCATCGACTTCTGCACGGAACCCTTACTGGCCGCCACCGAGACTGAACGCGTACTGTCCCTCGGCGGCCAGTTCTACCGCGTCGAGCTGGAGACCGCACCGGCCGCCGGGATCAGCCGCCTCCAGGAGGAGATCACCGCACGGCTGGCGAAGCTCTCCGGCGGGGTCTTCCCGTACTGGACCAAGGGACAGCGCCGGCGCGTGCACCAGTGGCTCACCGGCCGCGGCTTCGCGCACCGCAGGATCCGCCTCGCGCGGTGGAACGAGACGCGAAGCCTGCGCAACTGGCTCCAGGGCCTGGTCAACGCGAGCTATCCCTCCTTCTCGGGCGTCGACGAGCAGACGGCTGAGTCCGTCTGCCTGGAACTGGCGAGTGCCGCGTCGATGGGAGACCTCGACACCACGTGGGACGGAGAAGTCGGCGTGGTGGTGCACCAGTACGAGGCCGTCGACCGGTGCTGTTCCTCGCACCGCCCGGGCCGACGTCTCGTCTGA	MIPDRSKPPSRTSTAIDLVRETGDVTDLPACDSRFHYVPPWRVAALETLAEKVLPPVADLAARYSAAGRMEDLITADETATLMDACAFVRLRGARDGCTLAFGGLPPELTEYGRRERMTVRAALECVGWFDANQRHLTTVDIAPGRPAGAQPVDGALYGAELARRYDPARQVTERFNDVLRAFAKEFLGTRRVLELGAGTGRVGRNIAPFAGSYAGIEASHAMISAGRRYGLDVRHGDMMAMPFETGSFDAVVEHESIDFCTEPLLAATETERVLSLGGQFYRVELETAPAAGISRLQEEITARLAKLSGGVFPYWTKGQRRRVHQWLTGRGFAHRRIRLARWNETRSLRNWLQGLVNASYPSFSGVDEQTAESVCLELASAASMGDLDTTWDGEVGVVVHQYEAVDRCCSSHRPGRRLV	MARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRARRELSQNFLARRAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLLPALRDRFGGPHHAHVRISGGDFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSATFVTQLEYARKRTGDYGRWSLLTVRTWPRHEWRLLGRVSRREFRPVPRVDSGILRIERRERPLLPSAALGDYHRMVELGFSGVGGSLYASLRRAHRAGPLDAAFRAARLDRSVVVAYVTPEQWLTVFRTLRPVRSRPAGR	131.66	gnl|BL_ORD_ID|671|hsp_num:0	727			183	456	lincomycin; tylosin; pristinamycin IC; carbomycin; niddamycin
BGC0000872.1|A-90289_28 # 30214 # 30834 # 1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.676	BGC0000872.1|A-90289_28 	30214	30834	+	Loose	375	85.5001	tmrB	38.33	3003059	protein homolog model	n/a	n/a	nucleoside antibiotic	reduced permeability to antibiotic	tunicamycin resistance protein	GTGCTGTTCCTCGCACCGCCCGGGCCGACGTCTCGTCTGAGAACGGAGAAAGACGTGCTGGTGTGGATCAACGGCGCTTTCGGAGCCGGCAAGTCGAGCGTCACCGAGGAAGTGACACGGGCCGTCGGCGAGGTCATCGTCTTCGACCCCGAAGAGGTCGGCTTCCATCTGCGCACCTGGGTGCCGCTGCCGGCGTCACAGGACTTCCAGGACCTCGCCTGCTGGCGCGATGTCGTGGGACAGACATGCGCGGCGTTCGAACGCCACTACCCGTCCCGGCTCCTCCTCGTGCCGATGACCGTGGTGAACGACGACTACCGGCGGGAGATCTTCGACATCATCCATCAGAGCACGGACGACGTTCTGCACGTCTGGCTCTCGGCCACCCGGCAGACGCTCACCGACCGCATCACCCGGCAGGTCGTGTGGCCGGACGACCCCGAACGGGACGCCGAGGTGAGGGCCTGGCGCCTCGCGCAGATCGACGGCGCGATGACCGCCGAGAGGCGACTTGGCGCGGACACCGTTCTCCTGCCCACGGACGACACGAGTCCACGCCGGCTGGCCGAACGCATCCTCTCCGAAGCAGGCAGGCGCACCGGAAGGGACTCGCGTCCATGA	MLFLAPPGPTSRLRTEKDVLVWINGAFGAGKSSVTEEVTRAVGEVIVFDPEEVGFHLRTWVPLPASQDFQDLACWRDVVGQTCAAFERHYPSRLLLVPMTVVNDDYRREIFDIIHQSTDDVLHVWLSATRQTLTDRITRQVVWPDDPERDAEVRAWRLAQIDGAMTAERRLGADTVLLPTDDTSPRRLAERILSEAGRRTGRDSRP	MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLWRAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSLRRFADRLMVKLNHIRIK	104.57	gnl|BL_ORD_ID|1654|hsp_num:0	1794			0	357	tunicamycin
BGC0000872.1|A-90289_30 # 32136 # 32933 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=6bp;gc_cont=0.672	BGC0000872.1|A-90289_30 	32136	32933	+	Loose	900	26.1794	tet(O/W)	29.09	3007121	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGACGACCGCCGAAACCGCAACCCCCCACGACAACGCCGCGGACGCCTACCTAGACCTGCTGAAGCGCTGCCTGACCCGATATGACGGCCGGCAGATCTTCCTCGGCCCGCCGCTGACGAAGCCGCGCACCATGGAACAGATAGAGCGGGGCCGGTTCGCCCACCAGGACGCCGACACCATGATCGGATGGCCACGCCTGGACAACGTCCGTCACTGCGTGGAGACCGTGCTCCGGGAGAAGGTGCCGGGAGACCTGCTCGAAGCGGGTGTGTGGCGAGGCGGCTGCTGCGTCTTCATGCGCGGCATCCTCAAGGCGCGGGGTGTGACCGACCGCACGGTGTGGGTGGCCGACTCGTTCGCCGGGTTCCCCGAGCCGGACACCGGCCGGTATCCGGACGACTCCGTCTACGACGGTCCCGTCGCGCGGGAGATCCTCGACGGCTTCGGATACCCGATCGCCATCGGCCTGGACGAGGTGAAGGCCCGATTCACGTCCTACGGACTGCTGGACAGTCAGGTGCGGTTCCTCGTGGGCTACTTCGCGGACACGCTGCCGCAGGCCCCGGTCGAGCGGCTGTCCGTTCTGCGGCTGGACGGCGACATGTACCAGTCGACGCTGGAGTCCCTGGAGTACCTGTACCCGAAGCTGTCGGCCGGGGGTTTCTGCATCATCGACGACTACTCCTTGGAGGGCTGCCGCAAGGCCGTCGAGCACTTCCGCGAGGCGCACGGGATAACGGAGCCGATCGAGAAGATCGACTGGACCGGGGTCTTCTGGCGGAGGACTTCCCGGTGA	MTTAETATPHDNAADAYLDLLKRCLTRYDGRQIFLGPPLTKPRTMEQIERGRFAHQDADTMIGWPRLDNVRHCVETVLREKVPGDLLEAGVWRGGCCVFMRGILKARGVTDRTVWVADSFAGFPEPDTGRYPDDSVYDGPVAREILDGFGYPIAIGLDEVKARFTSYGLLDSQVRFLVGYFADTLPQAPVERLSVLRLDGDMYQSTLESLEYLYPKLSAGGFCIIDDYSLEGCRKAVEHFREAHGITEPIEKIDWTGVFWRRTSR	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDALLEKYIAGEPISQEKLAREEQRRVQEASLFPVYHGSAKKGLGIQPLMDAVTGLFQPIGEQGSATLCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWREAPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKIETVVKEPTVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQSVCLTELKGYQAAVGQPVIQPRRPNNRLDKVRHMFQKVM	41.47	gnl|BL_ORD_ID|4795|hsp_num:0	5791			1806	1917	tetracycline
BGC0000872.1|A-90289_31 # 32930 # 34132 # 1 # ID=1_31;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.695	BGC0000872.1|A-90289_31 	32930	34132	+	Loose	2200	27.335	rpoB2	41.03	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGACCGCGGCGCCGCGAAGCCCGTGGGGAGAGGTGCCCCCGGCGGAGAGCACCATCGCCCGGGTGATCTCGGCGGCCGGCTGCCGGGAGGAGGAGATCGCCTCGGTCGTCGACTCCTCCGGCCCCGAGAGGGTGGCCGAGATCCTGGTGGACGAGATCGTGTGCAGGATGGACCTGCCCCCGGTCGAGCTCGACCAGGAGATCGTGGTCCAACTGCTCTTCACGCACGGGGCGAAGAGCGTCGCCCACCTCGTGAAGGCCGGCTCGGCCGGTGCGACGTGCGAACCGGGTGAAGCGCCGGAGCCGCACGCACGCATCGAGCAGGACCTGTGCGAGGCAGTGCGGGCGGTGTTCGGGCCGAGCGGCGATCGCGCGGCGGCGACAAGGCGGCTGGAGCTGCGCGGATCGGGGACCCCGCAGGCGTTCGTACAGCCGCCCACGGCGTTCTGGGTGACACAGCGGTTGCTCGCGACCATGGACGACCGCGATCAGATCGGCCTGACCGAGCTGGCCAGTCGCCACGGCTCGGACAAGTGGGGCATCCACCACTACACCCGCCACTACCAGCATCACTTCGAGCCGCTGCGCGATCGACCACTGACCGTTCTGGAGATCGGCGTCGGGGGCCTCAGCGGCGGCTCCACCGGCTACGGTGCCCCGGACAAGGGCGGCGGCTCGCTGCGGATGTGGAAGCGGTACTTCCCGCGCGCCCTGGTCTACGGCATGGACGTCGCCGACAAACAGGCGCTGTCCGAGCAGCGGATCACCGTTCTGCGCGCCGATCAGTCCGACCCCGCCGAACTGCGTCGGGTGGTCGAGGAAACGGGGCCCCTGGACATCGTCATCGATGACGGCAGCCATCGCAGCGAGCACGTGCTGACGTCCTTCCACACGCTGTTCCCGTACGTGCGGAACGGGGGCCTGTACGTGATCGAGGATCTGCAGACCTCCTACTGGCCGCGGTTCGGCGGGAACAGCGAGGTGTTCGACAGCCCCACGACGAGCGTCGGGTTCCTGAAGTCCCTGGTCGACGGCCTGAACCACGAGGAGATCCTGGACTCCGGCGGGCGGGCCCCCGGGGCGCACGACCGGCACATCAAAGGCCTGCACTTCTACCACAACATCGTCTTCGTCGAGAAAGGACTGAACGCGGAGGGTGGCGGCCCCGCCTGGCTCAGGCATCCGCCCCGTCGGCGTCAGTGA	MTAAPRSPWGEVPPAESTIARVISAAGCREEEIASVVDSSGPERVAEILVDEIVCRMDLPPVELDQEIVVQLLFTHGAKSVAHLVKAGSAGATCEPGEAPEPHARIEQDLCEAVRAVFGPSGDRAAATRRLELRGSGTPQAFVQPPTAFWVTQRLLATMDDRDQIGLTELASRHGSDKWGIHHYTRHYQHHFEPLRDRPLTVLEIGVGGLSGGSTGYGAPDKGGGSLRMWKRYFPRALVYGMDVADKQALSEQRITVLRADQSDPAELRRVVEETGPLDIVIDDGSHRSEHVLTSFHTLFPYVRNGGLYVIEDLQTSYWPRFGGNSEVFDSPTTSVGFLKSLVDGLNHEEILDSGGRAPGAHDRHIKGLHFYHNIVFVEKGLNAEGGGPAWLRHPPRRRQ	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	34.42	gnl|BL_ORD_ID|2431|hsp_num:0	2831			2850	2964	rifampin; rifaximin; rifabutin; rifapentine
BGC0000872.1|A-90289_32 # 34192 # 35385 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.723	BGC0000872.1|A-90289_32 	34192	35385	+	Loose	700	72.7886	oleI	40.65	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGTGTGTTGTTCACGACGTCCCCCGGGCTGGGGCACATGTTCCCGGTCGTCTCGCTGGCCTGGGCGCTGCGCGCGGCCGGACACGAGATTCTGCTGGCCACCGCCGGCCGGGCGGACGGCCACATCCGGGCGGTGGTGCACGCCGGCCTGCCCGTGGTGGAGGCACTGAGCACCGAACGGGCGGGCAATGCCTTCGCCTTCGGGATCAGCGCCTGGCTGAAGCAGGAAGGCAGGTCCGTGGCCGGGAGGCCGGACTGGTCCCGGCACGTCGGCAAGGAGCTGGCGCGCAACGGCGGTTCTCTGGCAACCGTCGCCCCCATGTACGCCCCGCTCTCCATGGCCATGAGCACCGAGGTGGTGGCCGTCGCCGAGCAGTGGCGGCCGGAACTGATCGTGCACACACCCCTGGAAGGAGCCGGGCAGCTGGCCGCTGCCAAGCTCGGTGTCCCCGCAGTCGAGCAGCCGTTCGGATTCACCCGTAACGACGGGATCGCTCCCGTGCTGCGGACGGCGATGGACCGGGCCTACCGTGCGCACGGCGTGGCCGGGCTGCCCGAGCGGAGGATCGCCCTGTCCATCACCCCGCCGAGCATGGCGGGCGGGGTGACCCCGGGATGGCCGATGCGATACGTGCCGTTCAACGGCGGCGGGCTGCTGGCCGACTGGCTGCGGACGCCGCCGGACCGTCCCAGGGTGGCACTCACCCTGGGCTCCGAGGTGGTGCAGTGGCACGGCGAGCTCGGCCCGCTGGCCTGGGTCGCGCAGGTGGCCGCGAACGTGGACGCCGAGTTCGTGCTCGCCGTCGGCGACGACGTCGACCCGGCGCAGCTCGGCGAGCTGCCGGAGAACGTGCGGCCGGCCGGGTACGTCCCGCTCAACCAGCTGTTGTCCACCTGCTCGGCGGTCGTCCACCACGGCGGGTCCGGAAGCACCATGGCTGCACTGGACGCGGGGATCCCGCAACTGATCCTGCCGCAGAGCGCGGACCAGTTCATCAACGCCGATGCGGTGACCGGGCGGGGGTGCGGTCTGACGGTGGAAGGCGCAGTGGACGCCGACCTGATGGTCCGGCTGCTCACCGACCCGGAACCGGCGGAGGCCGCGGCGCAGGTCCGGGCCGAACTGCATGACATGCCTACGCCCGCCGAGGTGGTGCCCAGGCTGATCGAATGGGCGCGGGGGACGTCGTAG	MRVLFTTSPGLGHMFPVVSLAWALRAAGHEILLATAGRADGHIRAVVHAGLPVVEALSTERAGNAFAFGISAWLKQEGRSVAGRPDWSRHVGKELARNGGSLATVAPMYAPLSMAMSTEVVAVAEQWRPELIVHTPLEGAGQLAAAKLGVPAVEQPFGFTRNDGIAPVLRTAMDRAYRAHGVAGLPERRIALSITPPSMAGGVTPGWPMRYVPFNGGGLLADWLRTPPDRPRVALTLGSEVVQWHGELGPLAWVAQVAANVDAEFVLAVGDDVDPAQLGELPENVRPAGYVPLNQLLSTCSAVVHHGGSGSTMAALDAGIPQLILPQSADQFINADAVTGRGCGLTVEGAVDADLMVRLLTDPEPAEAAAQVRAELHDMPTPAEVVPRLIEWARGTS	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	93.63	gnl|BL_ORD_ID|1684|hsp_num:0	1824			846	1209	oleandomycin
BGC0000872.1|A-90289_26 # 28077 # 28955 # 1 # ID=1_26;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.719	BGC0000872.1|A-90289_26 	28077	28955	+	Loose	660	48.1358	MexS	33.97	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGCGCGGCGTCGGGATCAACCGCGACCAGTACCCGCGCATCCTCGGCTGCGAGGCGGCGGGAGAGGGCCCCGACGGAGCGAGGGTGGTGCTGTATCCGCTGCTCGACTCCCCACCGGGCATGAGCGACGAGACGCTGGTGATGCCCGCGGCCCAGCTGGCCGGTGCCCGGCCGGGCACACTGGCCGAGTACTTCGCCGCACCCCCCGAGAGCCTGCTGCCGGTCCCGGACCACCTGTCCTGGGAGGAGGCCGCGTGCCTGGTGTGTACCTGGCTGCCCGCCTACCGGATGCTGTTCACGAAGGCGGCACTGCGCCCCGGGGACACCGTGCTCGTCCAGGGCGCGGCGGGCGGTCTGTCCACTGCGCTGATCAGCCTGGCCGCGGCGGCCGGCCTGCGCACCTGGGTCACCGGCCGCTCCGCCGACAAGCGGGAGCTGGCTCGCCGGCTGGGAGCGAGTGACGTGTTCGAGCCGGGATCCGCGCTGCCCGAATCGGTCGACGCGGTCATCGACAGCGTGGGCAAGGAGACATGGACGCACTCGCTGCGCAGTGTCCGGCACGGCGGAACACTGGTGGTCGCCGGTGCGACCACGGGAGACGTGCCGCCGGCCCGGCTGCACCGCGTGTACTTCCACCAGGTCAACGTCGTGGGGTCCTTCAGCGGTACGCGGGAGGAATACCGGCGCATGGTGACCTTCATGCGCACCACCGGCATCAGGCCGCTGGTGGACGATGTGCTGCCGGTCCAGGAGGCTCGCGCGGCACTCAAGCGGCTCGCCGACGGCGACGTGCGAGGCAACCTGGTCCTCACCTGGCCCGAGGAAGACCAGGAATCCCGCTCCGAGGCGGCTCGGCGACTCTCCGTCTGGGTCCCCTGA	LRGVGINRDQYPRILGCEAAGEGPDGARVVLYPLLDSPPGMSDETLVMPAAQLAGARPGTLAEYFAAPPESLLPVPDHLSWEEAACLVCTWLPAYRMLFTKAALRPGDTVLVQGAAGGLSTALISLAAAAGLRTWVTGRSADKRELARRLGASDVFEPGSALPESVDAVIDSVGKETWTHSLRSVRHGGTLVVAGATTGDVPPARLHRVYFHQVNVVGSFSGTREEYRRMVTFMRTTGIRPLVDDVLPVQEARAALKRLADGDVRGNLVLTWPEEDQESRSEAARRLSVWVP	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	86.14	gnl|BL_ORD_ID|1039|hsp_num:0	1041			174	582	ciprofloxacin; trimethoprim; chloramphenicol
